TITLE

Cryptogenic fibrosing alveolitis with preserved lung volumes

AUTHOR(S)
Doherty, M. J.; Pearson, M. G.; O'Grady, E. A.; Pellegrini, V.; Calverley, P. M. A.
PUB. DATE
November 1997
SOURCE
Thorax;Nov1997, Vol. 52 Issue 11, p998
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66299166

 

Related Articles

  • Cryptogenic Fibrosing Alveolitis Predating Ulcerative Colitis. De Llano, Luis A. Pérez; Lancho, Angel; Del Cerro, J. L. Soilán; López-Rosés, Leopoldo // American Journal of Gastroenterology;Apr1996, Vol. 91 Issue 4, p822 

    Presents a letter to the editor on cryptogenic fibrosing alveolitis predating ulcerative colitis.

  • Minerva.  // BMJ: British Medical Journal (International Edition);04/11/98, Vol. 316 Issue 7138, p1178 

    Presents information on developments in medicine. Information on injuries from snowmobiles; Account on an approach for treating metastatic breast cancer; Survival period of patients with cryptogenic fibrosing alveolitis.

  • Pulmonary Fibrosis.  // Current Medical Literature: Respiratory Medicine;2010, Vol. 24 Issue 1, p23 

    The article reviews several studies on pulmonary fibrosis. It cites an investigation on the effect of bosentan in patients with idiopathic pulmonary fibrosis (IPF) in the Bosentan Use in Interstitial Lung Disease-1 (BUILD-1) trial which note that endothelin antagonists do not have any proven...

  • SCIENTIFIC FRONTIERS IN LUNG DISEASE.  // Thorax;Dec2001 Supp, Vol. 56, piii41 

    This article presents various studies related to scientific frontiers in lung disease. The immune pathology of sarcoidosis is characterized by an exaggerated CD4 T cell response to an undefined antigens. Spontaneous remission occurs in the majority of subjects, but 30% of patients develon...

  • What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. Scott, Jonathan; Johnston, Ian; Britton, John // BMJ: British Medical Journal (International Edition);11/3/90, Vol. 301 Issue 6759, p1015 

    Examines the etiology of cryptogenic fibrosing alveolitis in Nottingham, England. Role of the occupational and domestic exposure to dust for the development of the disease; Survival of patients after a month of diagnosed; Evaluation of the restrictive pulmonary function test for the investigation.

  • Rising mortality from cryptogenic fibrosing alveolitis. Johnston, Ian; Britton, John; Kinnear, William; Logan, Richard // BMJ: British Medical Journal (International Edition);11/3/90, Vol. 301 Issue 6759, p1017 

    Examines the mortality rate caused by cryptogenic fibrosing alveolitis in Great Britain. Identification of factors important in the etiology of the disease; Assessment of the validity of death certification of the disease; Treatment and management of the disease.

  • Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Bernstein, R.M.; Morgan, S.H.; Chapman, J.; Bunn, C.C.; Mathews, M.B.; Turner-Warick, M.; Hughes, G.R.V. // British Medical Journal (Clinical Research Edition);7/21/1984, Vol. 289 Issue 6438, p151 

    Discusses the function of anti-jo-1 antibody in patients with myositis and cryptogenic fibrosing alveolitis in Great Britain. Definition of myositis; Identification of the antibody by counterimmunoelectrophoresis; Usage of cytotoxic drugs.

  • What is this thing called CFA? Wells, A. U.; Hansell, D. M.; Nicholson, A. G. // Thorax;Jan2007, Vol. 62 Issue 1, p3 

    The article discusses various reports published within the issue, including one by R. Rudd, R.J. Prescott and JC Chalmers regarding cryptogenic fibrosing alveolitis.

  • Diagnosis and management of idiopathic pulmonary fibrosis. Walling, Anne D. // American Family Physician;5/15/1998, Vol. 57 Issue 10, p2527 

    Presents information from the article `Cryptogenic Fibrosing Alveolitis,' by M. Chang-Yeung and N.L. Muller, which was published in the 1997 August issue of the `Lancet' journal. Prevalence of idiopathic pulmonary fibrosis in the United States; Therapy used to treat pulmonary fibrosis;...

  • Interstitial lung disease: progress and problems. Bourke, S. J. // Postgraduate Medical Journal;Aug2006, Vol. 82 Issue 970, p494 

    Interstitial lung disease involves all areas of medicine as it often occurs in patients with comorbidities or as a consequence of systemic diseases and their treatment. Typically the physician is faced with a breathless patient, a diffusely abnormal chest radiograph, and a wide differential...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics